Introduction {#Sec1}
============

Respiratory distress syndrome (RDS) is a major cause of morbidity and mortality in premature infants.^[@CR1]^ Newborns and particularly preterm infants are at high risk of oxidative stress and are susceptible to free radical oxidative damage.^[@CR2],[@CR3]^ The pathogenesis of oxidative stress in RDS is based on the rapid formation of the reactive oxygen species (ROS), which overcome the capacity of the antioxidative defense system.^[@CR4]^ ROS can cause damage to a variety of cellular molecules, including lipids, proteins, and DNA, which results in cell injury and may induce respiratory cell death.^[@CR5],[@CR6]^ ROS also interact with pulmonary surfactant, thus delaying the normal functioning of the lung.^[@CR5]^ This process can contribute to the pathogenesis of RDS and very likely leads to severe RDS.^[@CR7]^

ROS have been implicated in the molecular damage seen in the bronchoalveolar lavage (BAL) fluid of patients with RDS. BAL fluid normally contains a large amount of the antioxidant glutathione; but in patients with RDS, it is mostly in the oxidized form. Hydrogen peroxide was detected in the expired air of RDS patients.^[@CR4]^ Moreover, in neonates with RDS and bronchopulmonary dysplasia (BPD), lipid hydroperoxide is increased and glutathione concentrations are decreased in BAL fluid.^[@CR8]^

Malondialdehyde (MDA) is one of the most frequently used indicators of the overall lipid peroxidation.^[@CR9]^ Advanced oxidation protein products (AOPPs) is a protein oxidation biomarker, which originates under oxidative and carbonyl stress and increases global inflammatory activity.^[@CR10],[@CR11]^ 8-Hydroxy-2-deoxyguanosine (8-OHdG) is a commonly used marker of oxidative stress-derived DNA damage.^[@CR12],[@CR13]^

Total antioxidant capacity (TAC) evaluates the overall antioxidant status resulting from antioxidant production and consumption in response to oxidative stress.^[@CR14]^ Thus, TAC provides an integrated parameter rather than the simple sum of measurable antioxidants.^[@CR15]^ Trace elements such as copper, manganese, selenium, and zinc act as cofactors of antioxidant enzymes to protect the body from oxygen free radicals that are produced during oxidative stress. It is necessary to maintain a balance between the harmful pro-oxidant components produced and the antioxidant compounds that counter these effects.^[@CR16]^

Identification of the potential biomarkers of oxidative stress in RDS that could monitor disease progression represents a promising challenge. To test the hypothesis that the presence of oxidant--antioxidant imbalance in preterm neonates contributes to the development and severity of RDS, this study assessed lipid peroxidation, protein oxidation, and oxidative DNA damage in relation to neonatal RDS severity.

Patients and methods {#Sec2}
====================

Study population {#Sec3}
----------------

This prospective study was carried out in the neonatal intensive care unit (NICU), Ain Shams University Hospitals. Informed consent was taken from the parents or caregivers of each participant before enrollment. This study was approved by the ethical committee of Ain Shams University and is in accordance with the Declaration of Helsinki of 1975.

This study included 80 preterm neonates \<34 weeks gestational age. Neonates with respiratory distress due to causes other than RDS, major malformations and genetic disorders, fetal distress, difficult delivery, infant of diabetic or hypertensive mother, neonatal sepsis, hemolytic diseases, and hyperbilirubinemia were excluded from the study.

Cord blood samples were withdrawn from all neonates at birth. Samples were centrifuged and then stored at −80 °C. Out of 162 neonates assessed for eligibility, 38 did not meet the inclusion criteria, 49 were excluded, and 11 guardians declined to participate. Thus, 113 preterm neonates were followed up for the first 12 h of life and 40 neonates of them had established the diagnosis of RDS (RDS group). Neonates were considered to have RDS if they had marked respiratory distress with tachypnea, nasal flaring, grunting, and subcostal, intercostal, and/or suprasternal retractions at birth combined with radiological findings on chest X-ray.^[@CR17]^ They were compared with 40 consequently born healthy preterm neonates (control group). Neonates were considered to be healthy controls if they had no signs of respiratory distress or any other medical problem and did not need any respiratory support.

Perinatal history and clinical examination {#Sec4}
------------------------------------------

Detailed perinatal history was obtained for all neonates, followed by a thorough clinical examination focusing on maternal diseases, premature rupture of membranes, maternal medication during this pregnancy, antenatal steroids, surfactant administration, and the need for mechanical ventilation. Gestational age was determined using Ballard scores.^[@CR18]^ Apgar score at 1 and 5 min was assessed.^[@CR19]^

RDS grading and respiratory management {#Sec5}
--------------------------------------

Grading of RDS was done according to chest X-ray findings: grade I---fine, diffuse reticulogranular pattern over the lung fields, grade II---a denser lung with the presence of air bronchogram, which overlaps the heart, grade III---increased density and the presence of air bronchograms beyond the heart border, and grade IV---white lung.^[@CR20]^

Our NICU protocol is to initiate continuous positive airway pressure (CPAP) from birth with early selective surfactant administration for babies showing signs of RDS and needed more than 30% inspired oxygen to maintain saturation in the normal range using the INSURE (intubate--surfactant--extubate to CPAP) technique.^[@CR21]^ Age of start of mechanical ventilation, maximum positive inspiratory pressure (PIP), and maximum positive end expiratory pressure (PEEP) were recorded and oxygenation index was calculated.^[@CR22]^ The ventilator parameters were adjusted according to the clinical condition, arterial blood gases, and chest X-ray.

Laboratory analysis {#Sec6}
-------------------

For laboratory analysis, cord blood samples were collected on day 0 of life from preterm neonates with RDS and controls, then peripheral blood samples were obtained on day 3 from neonates with RDS. Serum levels of AOPPs and 8-OHdG were assessed by enzyme-linked immunosorbent assay using kit supplied by SunLong (SunLong Biotech Co., Ltd, Zhejiang, China). Serum TAC was assessed using colorimetric kit (Bio-Diagnostics, Egypt, Cat. No., MD 2513). Serum levels of MDA were determined by measuring the production of thiobarbituric acid reactive substances (TBARS) using colorimetric kit (Bio-Diagnostics, Egypt, Cat. No., MD 2529). Quantitative determination of serum copper and zinc was done using SOLAR system Unicam 939 atomic absorption spectrometer (Unicam, Cambridge, UK).

Follow-up {#Sec7}
---------

All included neonates with RDS were followed up to assess disease progression and mortality, as well as duration of mechanical ventilation and duration of hospitalization. Patients were also evaluated for other comorbidities: intraventricular hemorrhage, patent ductus arteriosus, pulmonary hypertension, pneumothorax, pulmonary hemorrhage, BPD, necrotizing enterocolitis, and retinopathy of prematurity.

Primary and secondary outcomes {#Sec8}
------------------------------

The primary outcome was to assess the levels of AOPPs and 8-OHdG along with MDA, TAC, and trace elements in neonates with RDS and healthy controls. Secondary outcomes included duration of mechanical ventilation, duration of hospitalization, and mortality, as well as examining the relation between oxidative stress markers (AOPPs and 8-OHdG) and the degree of RDS.

Sample size calculation {#Sec9}
-----------------------

Using STATA program, setting α-error at 5% and power at 90%, results of a previous study^[@CR5]^ showed that the mean 8-OHdG in cases was 39.6 ± 11.5 compared with 23.35 ± 7.6 in controls. Based on these values, a sample of at least 15 preterm neonates per group was calculated; however, we included 40 cases and 40 controls to achieve a better statistical power.

Statistical analysis {#Sec10}
--------------------

Analysis of data was done using Statistical Program for Social Science version 21 (SPSS Inc., Chicago, IL, USA). Qualitative data were presented as number and percentages, while quantitative data were presented as ranges, mean and standard deviations, or median and interquartile range. In order to compare quantitative parametric variables between three groups, analysis of variance (ANOVA) test with post hoc test was used, while for comparing two groups, Student's *t* test was applied. Comparison of nonparametric variables was carried out using Mann--Whitney tests. Qualitative variables were compared using *X*^**2**^ test or Fischer's exact test when frequencies were below five. Pearson's or Spearman's correlation coefficients were used as appropriate to assess the correlation between two quantitative parameters in the same group. Multivariable linear regression analysis was employed to determine the relation between oxidative stress markers and clinical, laboratory, and radiological variables. Logistic regression analysis was performed with estimating the odds ratio (OR) and 95% confidence interval (CI) to define predictors of RDS severity. Receiver operating characteristic (ROC) curve was used to determine the best cutoff values of AOPPs and 8-OHdG that could predict RDS severity and mortality with the highest balanced sensitivity and specificity. The area under the curve (AUC) was calculated for each plot. A *p* value \<0.05 was considered significant in all analyses.

Results {#Sec11}
=======

The clinical characteristics of neonates with RDS were shown in Table [1](#Tab1){ref-type="table"}. Gestational age and birth weight were significantly lower among neonates with RDS than controls (30.9 ± 1.9 vs. 33.6 ± 0.5 weeks and 1.58 ± 0.43 vs. 2.29 ± 0.06 kg, respectively; *p* \< 0.001). RDS group included 25 males and 15 females with a male to female ratio of 1.7:1, while the control group included 26 males and 14 females with a male to female ratio of 1.8:1 with no significant difference in sex distribution between both groups (*p* \> 0.05). No significant difference was found between mothers of neonates with RDS and control group as regards maternal age, mode of delivery, and antenatal steroid intake (*p* \> 0.05).Table 1Clinical characteristics of neonates with RDSVariablesRDS group (*n* = 40)Gestational age (weeks), mean ± SD30.9 ± 1.9Males, *n* (%)25 (62.5)Birth weight (kg), mean ± SD1.58 ± 0.43Apgar score, median (IQR)  1 min6 (5--7)  5 min7 (7--8)Age of start of mechanical ventilation (h), median (IQR)6 (3--8)Duration of mechanical ventilation (days), median (IQR)7 (5--10)Type of respiratory support, *n* (%)Non-invasive mechanical ventilation   NCPAP9 (22.5)   NIPPV5 (12.5)Invasive mechanical ventilation   CMV18 (45)   HFV8 (20)Maximum PIP (CmHO~2~), mean ± SD16.4 ± 1.01Maximum PEEP (CmHO~2~), mean ± SD4.4 ± 0.5Oxygenation index, mean ± SD  Before surfactant treatment30.1 ± 6.3  After surfactant treatment^a^12.8 ± 3.7RDS radiological grade, *n* (%)  I0 (0)  II12 (30)  III12 (30)  IV16 (40)Bronchopulmonary dysplasia, *n* (%)1 (2.5)Retinopathy of prematurity, *n* (%)1 (2.5)Necrotizing enterocolitis, *n* (%)0 (0)Pulmonary hypertension, *n* (%)0 (0)Pneumothorax, *n* (%)0 (0)Pulmonary hemorrhage, n (%)0 (0)Duration of hospitalization (days), median (IQR)13.5 (5.5--18.5)*RDS* respiratory distress syndrome, *IQR* interquartile range, *NCPAP* nasal continuous positive airway pressure, *NIPPV* nasal intermittent positive pressure ventilation, *CMV* conventional mechanical ventilation, *HFV* high-frequency ventilation, *PIP* positive inspiratory pressure, *PEEP* positive end expiratory pressure^a^Oxygenation index was assessed in 16 patients treated by surfactant

Comparison of hematological data on day 0 between neonates with RDS and the control group revealed no significant difference (*p* \> 0.05). As regards oxidative stress markers, we found that day 0 and day 3 levels of MDA, AOPPs, and 8-OHdG were higher in neonates with RDS compared with control group, while TAC, zinc, and copper were lower on day 0 and day 3 (*p* \< 0.05 for all) (Table [2](#Tab2){ref-type="table"}). Moreover, upon comparing the oxidative stress markers among neonates with RDS on day 0 and day 3, MDA, AOPPs, and 8-OHdG were increased on day 3, while TAC and zinc were decreased on day 3 (*p* \< 0.001 for all) (Table [2](#Tab2){ref-type="table"}).Table 2Oxidative stress markers among neonates with RDS and control groupsVariablesControl group (*n* = 40)RDS group (*n* = 40)*P* valueDay 0Day 3RDS Day 0 vs. controlRDS Day 3 vs. controlRDS Day 0 vs. RDS Day 3TAC (mmol/L)3.3 ± 1.12.58 ± 0.811.1 ± 0.43\<0.001\<0.001\<0.001MDA (nmol/mL)8.8 ± 2.512.3 ± 4.320.4 ± 5.10.031\<0.001\<0.001AOPPs (ng/mL)27.0 ± 15.582.6 ± 48.0196.3 ± 63.1\<0.001\<0.001\<0.0018-OHdG (pg/ml)1200.0 ± 823.32562.5 ± 1166.86200.0 ± 2420.0\<0.001\<0.001\<0.001Copper (mg/L)0.71 ± 0.470.51 ± 0.190.35 ± 0.10.006\<0.0010.262Zinc (mg/dL)14.2 ± 6.19.1 ± 4.55.1 ± 2.20.003\<0.001\<0.001Data were expressed as mean plus or minus SD, where ANOVA with post hoc test was used for comparison between three groups*RDS* respiratory distress syndrome, *TAC* total antioxidant capacity, *MDA* malondialdehyde, *AOPPs* advanced oxidation protein products, *8-OHdG* 8-hydroxy-desoxyguanosine, *ANOVA* analysis of variance

Analysis of the levels of AOPPs and 8-OHdG in relation to maternal clinical characteristics of RDS group showed lower day 3 AOPPs levels among neonates born to mothers with antenatal steroid intake than those without (*p* = 0.003). As regards neonatal data, day 0 and day 3 AOPPs and 8-OHdG levels were significantly higher in neonates in RDS grade III and IV compared with those in grade II (*p* \< 0.05). Serum AOPPs levels on day 3 were also increased in neonates who received surfactant (*p* = 0.004). Moreover, levels of both markers were increased among patients on invasive mechanical ventilation and among those who died (*p* \< 0.05) (Table [3](#Tab3){ref-type="table"}).Table 3Levels of AOPPs and 8-OHdG in relation to neonatal clinical characteristics among the RDS groupVariablesNumber (%)AOPPs (ng/mL) Day 0*P* valueAOPPs (ng/mL) Day 3*P* value8-OHdG (pg/mL) Day 0*P* value8-OHdG (pg/mL) Day 3*P* valueAntenatal steroids intake  Positive24 (60)80.6 ± 48.40.794173.1 ± 57.80.0032458.3 ± 1250.40.4966000 ± 2595.90.529  Negative16 (40)85.6 ± 48.9230.9 ± 55.52718.8 ± 1048.36500 ± 2175.6PROM  Positive12 (30)80.14 ± 49.670.627204.58 ± 72.350.5912589.3 ± 1225.10.8286089.3 ± 2490.90.664  Negative28 (70)88.33 ± 45.39192.68 ± 59.712500 ± 10666458.3 ± 2330.2Sex  Male25 (62.5)82.4 ± 49.30.968192 ± 68.980.5892420 ± 1057.50.3256060 ± 2310.80.643  Female15 (37.5)83 ± 47.4203.3 ± 53.22800 ± 1333.66433.3 ± 2658.3RDS radiological grade  Grade II12 (30)40.8 ± 25.5\<0.001151.7 ± 50.70.0021625 ± 644\<0.0014416.7 ± 14590.001  Grade III and IV28 (70)100.5 ± 44.2215.4 ± 58.62964.3 ± 1113.36964.3 ± 2360.7Surfactant  Positive26 (65)80.9 ± 49.20.861230.6 ± 62.40.0042468.8 ± 1056.20.6845604.2 ± 2090.20.055  Negative14 (35)83.7 ± 48.2173.3 ± 53.22625 ± 1253.37093.8 ± 2665.9IVH  Positive8 (20)82.3 ± 46.30.97213.1 ± 61.50.102881.8 ± 1728.10.3476177.4 ± 2599.80.91  Negative32 (80)82.8 ± 50.5180.9 ± 61.82467.7 ± 965.56277.7 ± 1787.2PDA  Positive17 (42.5)78.5 ± 41.30.44186.6 ± 57.10.612500 ± 1322.80.7526473.6 ± 2573.70.50  Negative23 (57.5)85.8 ± 51.8199 ± 65.22619.1 ± 1035.65952.3 ± 2307.1Mechanical ventilation  Invasive26 (65)95 ± 42.40.024219.2 ± 58.90.0012942.3 ± 1098.40.0046865.4 ± 2463.90.016  Non-invasive14 (35)59.6 ± 3 0.7153.6 ± 47.31857.1 ± 969.34964.3 ± 1834.1Mortality  Alive34 (85)75.9 ± 44.90.032181.9 ± 55.3\<0.0012485.3 ± 1202.80.3255676.5 ± 2018.4\<0.001  Died6 (15)120.8 ± 51.1277.5 ± 38.93000 ± 894.49166.7 ± 2523.2Data were expressed as mean plus or minus SD, where Student's *t* test was used for comparisons*RDS* respiratory distress syndrome, *AOPPs* advanced oxidation protein products, *8-OHdG* 8-hydroxy-desoxyguanosine, *PROM* premature rupture of membranes, *IVH* intraventricular hemorrhage, *PDA* patent ductus arteriosus, *ANOVA* analysis of variance

Logistic regression analysis included all the significant variables between RDS grade II vs. grades III and IV revealed that maternal disease (rheumatic heart disease or bronchial asthma), gestational age, and day 0 levels of AOPPs and 8-OHdG were the significant independent variables related to RDS severity (Table [4](#Tab4){ref-type="table"}).Table 4Logistic regression analysis for predictors of RDS severityIndependent variablesOR95% CI for OR*P* valueLowerUpperMaternal disease7.7271.41642.1750.018Gestational age (weeks)0.2010.0740.5460.002Apgar score 1 min0.3430.0951.3480.103Apgar score 5 min1.0910.1201.4150.202Day 0 MDA (nmol/mL)4.6330.92823.1370.062Day 0 AOPPs (ng/mL)1.0561.0162.0980.006Day 0 8-OHdG (pg/mL)1.0021.0013.0030.008Dependent variable: RDS grade severity.*OR* odds ratio, *CI* confidence interval, *MDA* malondialdehyde, *AOPPs* advanced oxidation protein products, *8-OHdG* 8-hydroxy-desoxyguanosine, *RDS* respiratory distress syndrome

ROC curve analysis revealed that AOPPs cutoff value of 47 ng/mL at day 0 could predict RDS grade severity with a sensitivity of 95.4% and specificity of 80.1% and AUC 0.896, while 8-OHdG cutoff value of 2418 pg/mL at day 0 could predict RDS grade severity with a sensitivity of 84.3% and specificity of 94.7% and AUC 0.831. Furthermore, AOPPs cutoff value of 95 ng/mL at day 0 could predict mortality with a sensitivity of 86.1% and specificity of 89.8% and AUC 0.826. while 8-OHdG cutoff value of 7250 pg/mL at day 3 could predict mortality with a sensitivity of 92.3% and specificity of 93.4% and AUC 0.897.

Both AOPPs and 8-OHdG were positively correlated with each other (*r* = 0.503, *p* \< 0.001 and *r* = 0.622, *p* \< 0.001 on day 0 and day 3, respectively). Day 0 MDA was positively correlated to day 0 and day 3 levels of AOPPs (day 0: *r* = 0.553, *p* = 0.011 and day 3: *r* = 0.518, *p* = 0.033) and 8-OHdG (day 0: *r* = 0.721 and day 3: *r* = 0.78, *p* \< 0.001 for both). None of the studied biomarkers of oxidative stress was correlated to gestational age or birth weight (*p* \> 0.05).

AOPPs was positively correlated to oxygenation index (day 0: *r* = 0.512, *p* = 0.013 and day 3: *r* = 0.559, *p* = 0.002), duration of ventilation (day 0: *r* = 0.574, *p* = 0.02 and day 3: *r* = 0.692, *p* \< 0.001), and duration of hospitalization (day 0: *r* = 0.348, *p* = 0.028 and day 3: *r* = 0.387, *p* = 0.014). Similarly, 8-OHdG showed positive correlation with oxygenation index (day 0: *r* = 0.403, *p* = 0.03 and day 3: *r* = 0.354, *p* = 0.041), duration of ventilation (day 0; *r* = 0.436, *p* = 0.036 and day 3: *r* = 0.499, *p* = 0.008) and duration of hospitalization (day 0: *r* = 0.667, *p* \< 0.001 and day 3: *r* = 0.634, *p* \< 0.001) (Fig. [1](#Fig1){ref-type="fig"}). Multivariable regression analysis showed that oxygenation index, duration of ventilation, and day 0 levels of MDA and 8-OHdG were the significant independent variables related to day 0 levels of AOPPs among the RDS group (Table [5](#Tab5){ref-type="table"}).Fig. 1Positive correlations between day 0 levels of advanced oxidation protein products and duration of ventilation (**a**) and day 0 levels of 8-hydroxy-desoxyguanosine and duration of hospital stay (**b**) among neonates with respiratory distress syndrome (RDS)Table 5Multivariable regression analysis of the factors affecting day 0 AOPPs levels among the RDS groupIndependent variablesUnstandardized coefficientsStandardized coefficients*P* value*B*Standard error*β*Oxygenation index4.1561.2180.5210.003Duration of ventilation2.8170.6720.4190.023Duration of hospitalization7.0513.8160.2870.072Day 0 MDA (nmol/mL)7.8552.0040.6790.001Day 0 8-OHdG (pg/ml)1.8730.0340.4820.008Dependent variable: AOPPs*RDS* respiratory distress syndrome, *MDA* malondialdehyde, *AOPPs* advanced oxidation protein products, *8-OHdG* 8-hydroxy-desoxyguanosine

Discussion {#Sec12}
==========

In preterm babies, the perinatal transition is accompanied by the immaturity of the antioxidant systems and the reduced ability to induce efficient homeostatic mechanisms designed to control overproduction of cell-damaging free radicals.^[@CR23]^

The mean gestational age and birth weight was lower among our RDS patients than controls; yet, all the studied patients and controls were preterm neonates \<34 weeks gestational age. This difference could be explained by the fact that the risk of RDS is inversely proportional to gestational age and birth weight; RDS occurs in approximately 5% of near-term infants, 30% of infants \<30 weeks gestational age, and 60% of premature infants \<28 weeks gestational age.^[@CR24]^ Gestational age is considered as an independent predictor of RDS.^[@CR25]^ Moreover, in a report from the National Institute of Child Health and Human Development Neonatal Research Network, the incidence of RDS was 44% in infants weighing 501--1500 g, with 71% reported in infants weighing 501--750 g, 54% reported in infants weighing 751--1000 g, 36% reported in infants weighing 1001--1250 g, and 22% reported in infants weighing 1251--1500 g.^[@CR26]^ In the study by Negi et al.,^[@CR5]^ gestational age and birth weight were higher in control group than neonates with RDS.

Several reports discussed oxidative stress in preterm infants;^[@CR7],[@CR14],[@CR27]^ however, few studies have addressed the role of oxidative stress in pathogenesis of RDS.^[@CR5],[@CR28]^ In this context, Negi et al.^[@CR5]^ found convincing evidence of oxidative damage and diminished antioxidant defense in newborns with RDS. Results of logistic regression analysis showed a significant association of oxidative damage markers and total antioxidant status with the incidence of RDS in newborns.

In the current study, we found higher day 0 MDA levels in neonates with RDS compared with the control group that further increased on day 3 compared with day 0. This denotes increased lipid peroxidation in RDS, which comes in parallel with the disease progression. In agreement with our findings, Negi et al.^[@CR5]^ examined the product of lipid peroxidation, MDA, using TBARS assay in neonates with RDS and it was significantly increased in the RDS group than controls. Similar results were obtained by Matyas et al.^[@CR29]^ In another study, Elshemy et al.^[@CR28]^ assessed lipid peroxidation among RDS neonates using serum peroxide and found that it was significantly increased in RDS neonates.

In the view of protein and DNA oxidation process, our results showed a significant increase in day 0 levels of AOPPs and 8-OHdG in the RDS group compared with controls. These levels showed further increase at day 3 compared to day 0. Few studies reported that 8-OHdG^[@CR5]^ and protein carbonyl,^[@CR5],[@CR30],[@CR31]^ another marker for protein oxidation, were elevated in neonates with RDS compared to controls. This oxidative protein and DNA damage has been suggested to be one of the contributing factors to the pathogenesis of neonatal RDS.^[@CR5],[@CR32]^

Our results suggest that the severity of oxidative stress correlates with the severity of RDS; we observed that AOPPs and 8-OHdG levels on day 0 and day 3 were significantly higher in neonates with RDS grades III and IV compared with those having RDS grade II. Logistic regression analysis showed that these biomarkers were significant independent variables related to RDS severity and the cutoff for prediction of RDS severity was determined. In our study, day 3 AOPP levels were higher among patients who received surfactant. Furthermore, levels of AOPPs and 8-OHdG were increased among RDS patients who needed invasive mechanical ventilation support and were also higher in those who died. We found significant relations between the two markers and oxygenation index, duration of ventilation, and duration of hospitalization. The increase in levels of oxidative stress biomarkers on day 3 with increasing the severity of RDS and the use of invasive mechanical ventilation could be related to the use of exogenous oxygen. This points out to the deleterious effects of hyperoxia.

There exist, however, several potential causes of intra- and extracellular oxidant stress in the preterm newborns with RDS. The high inspiratory concentrations of oxygen required to achieve adequate arterial oxygenation and pro-oxidant drugs (e.g., non-steroidal anti-inflammatory drugs) can all promote ROS accumulation and the utilization and depletion of antioxidative factors.^[@CR4]^ Joung et al.^[@CR33]^ reported that 8-OHdG measured on day 3 was correlated with the duration of mechanical ventilation. In this context, Dursun et al.^[@CR34]^ stated that mechanical ventilation and CPAP can induce oxidative stress. These findings support those reported by Falk et al.,^[@CR35]^ who found that mechanical ventilation can induce oxidative stress, which plays a critical role in the occurrence of pulmonary injury in intubated neonates. Moreover, Gladstone and Levine^[@CR36]^ found that the amount of oxidatively modified protein may provide a quantitative assessment of oxygen toxicity. Gitto et al.^[@CR4]^ suggested that hyperoxic exposure itself, although essential for the survival of RDS infants, probably induces excessive production of ROS in the respiratory system.

We also found that day 3 levels of AOPPs were significantly lower in neonates born to mothers who received antenatal steroids, which is most likely because antenatal steroid administration reduces the incidence and severity of RDS.^[@CR37]^ Moreover, antenatal steroid intensifies that activity of the antioxidant enzymes: glutathione, superoxide dismutases, and catalases.^[@CR38]^

In the present work, there were significant positive correlations between AOPP levels at days 0 and 3 with MDA. Buonocore et al.^[@CR32]^ observed a positive correlation between AOPPs and total hydroperoxide (a derivative of lipid peroxidation). This implies that the oxidative stress damage is a parallel process involving both lipids and proteins proportionately.

We found that increased oxidative stress is accompanied by reduced antioxidant defense since day 0 and day 3 levels of TAC were decreased in patients with RDS compared with the control group, which may be due to its consumption. Furthermore, copper and zinc levels were significantly lower among the studied neonates with RDS than controls. An experimental model by Sarricolea et al.^[@CR39]^ has been developed to investigate the effect of copper deficiency on lung maturity in the newborn rat. A greater thickness of the air--blood barrier was observed in the lungs of the copper-deficient group, which might explain the RDS observed in this group.

The limitation of this study is that MDA was assessed by a colorimetric kit for TBARS. Although the rapidity, ease of use, and cost of this assay made it the most common method, it may limit the likelihood of detecting true differences in the level of lipid peroxidation. Therefore, it is important to use high-performance liquid chromatography assay for MDA as a reliable method to measure lipid peroxidation.^[@CR40]^ Investigation of other effective markers of lipid peroxidation (such as isoprostanes) or oxidative stress-induced changes in the antioxidant system (e.g., reduced glutathione/glutathione disulfide ratio) would provide additional information.

In conclusion, the increased lipid, protein, and DNA oxidation is accompanied by alterations in the antioxidant defense status, which may play a role in the pathogenesis and severity of RDS. AOPPs and 8-OHdG could be used as serum biomarkers for oxidative stress among neonates with RDS to monitor disease progression. Maternal antenatal steroid intake and limiting the exposure of the preterm infants to oxygen at high concentration and high positive pressure during ventilation might decrease the risk of oxidative stress among neonates with RDS. Investigating the relation between the studied markers and proinflammatory cytokines, such as interleukin-6 (IL-6) and IL-8, as well as other markers of oxidative stress, are warranted.
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